​

Funding Round

Series B - Exo Therapeutics

Series B - Exo Therapeutics

Investment Firm

Overview

Exo Therapeutics is a small molecule drug discovery and development company.

Announced Date

Oct 05, 2021

Closed on Date

Oct 11, 2021

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

Nextech Invest

Nextech Invest

Nextech Invest is a early_stage_venture and late_stage_venture and post_ipo and private_equity and venture firm.

Participant Investors

8

Investor Name
Participant InvestorBiotechnology Value Fund
Participant InvestorNextech Invest
Participant Investor6 Dimensions Capital
Participant InvestorNovartis Venture Fund
Participant InvestorCRV

Round Details and Background

Exo Therapeutics raised $78000000 on 2021-10-05 in Series B

Exo Therapeutics is a small molecule drug discovery and development company.

Company Funding History

2

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Dec 16, 2020
Series A - Exo Therapeutics
4-25.0M
Oct 05, 2021
Series B - Exo Therapeutics
9-78.0M

Recent Activity

There is no recent news or activity for this profile.